Antony A. Riley Purchases 22,514 Shares of Forte Biosciences, Inc. (NASDAQ:FBRX) Stock

Forte Biosciences, Inc. (NASDAQ:FBRX) CFO Antony A. Riley purchased 22,514 shares of Forte Biosciences stock in a transaction on Thursday, November 21st. The stock was bought at an average price of $5.55 per share, with a total value of $124,952.70. Following the transaction, the chief financial officer now owns 30,776 shares of the company’s stock, valued at approximately $170,806.80. This represents a 272.50 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Forte Biosciences Trading Up 2.3 %

Shares of Forte Biosciences stock opened at $16.00 on Friday. The stock has a 50 day moving average of $5.91 and a 200 day moving average of $2.71. Forte Biosciences, Inc. has a 12 month low of $4.11 and a 12 month high of $21.25. The firm has a market cap of $23.39 million, a PE ratio of -0.98 and a beta of 0.04.

Analyst Upgrades and Downgrades

Separately, Chardan Capital upped their price objective on Forte Biosciences from $3.00 to $64.00 and gave the stock a “buy” rating in a research note on Friday, November 15th.

Forte Biosciences Company Profile

Forte Biosciences, Inc operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc is headquartered in Dallas, Texas.